ReviewClinics in geriatric medicine2025
Considerations in the Diagnosis and Management of Bronchiectasis in Older Adults.
Review in Clinics in geriatric medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bronchiectasis in Older Adults: Distinctive Epidemiology, Etiology, Diagnosis, and Clinical Evolution Compared with Younger Populations.Drugs & aging · 2026Review
- Age-Specific Considerations in Bronchiectasis Management: Focus on Older Adults with Emphasis on Anti-inflammatory Treatment.Drugs & aging · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Bronchiectasis is characterized by chronic airway inflammation and scarring resulting in cough and recurrent respiratory infections. It is strongly associated with aging. Risk factors include impaired mucociliary clearance, structural lung and chest wall changes, aspiration, and comorbidities such as chronic obstructive pulmonary disease. Radiographic bronchiectasis is a common incidental finding in older adults; clinical diagnosis of bronchiectasis requires characteristic symptoms. Management involves both nonpharmacologic strategies (airway clearance, pulmonary rehabilitation) and pharmacologic therapies (antibiotics, inhaled treatments). Shared decision-making about treatment is essential and should take into account impact on quality of life, functional ability, cognition, comorbid conditions, and risks of polypharmacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.